Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-05-23 00:00:00 ET · period of report 2023-05-19 · accession 0001610717-23-000062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-05-23 | 2023-05-19 | TXG | Saxonov Serge | CEO, Dir | G - Gift | $0.00 | -460 | 27 | -94% | $0 |
| M | 2023-05-23 | 2023-05-23 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $55.06 | -2,602 | 895.3K | -0.3% | -$143.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-05-19 | G | D | 460 | $0.00 | 27 | I See footnote | — | — | (F1) The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee. |
| 2 | Common | Class A Common Stock | 2023-05-23 | S | D | 2,068 | $55.06 | 893,190 | D | — | — | (F2) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |
| 3 | Common | Class A Common Stock | 2023-05-23 | S | D | 534 | $55.06 | 895,258 | D | — | — | (F2) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. |